Abstract: Necrotic testicular tumors are relatively frequent and can present a significant diagnostic challenge. Because of differing treatments for seminomas versus nonseminomas, accurate diagnosis is critical. Eleven totally (n = 9) or almost totally (n = 2) necrotic testicular tumors were retrieved from our consult files.
T esticular tumors represent <1% of malignant tumors in males, but they are the most common solid malignancy of young men. 7 The vast majority (90%) are germ cell tumors. Although they are uncommon, postorchiectomy treatment modalities (ie, chemotherapy, radiation, and surgery) play an important role in patient outcome. As treatment varies by histologic type, accurate diagnosis of testicular tumors is critical. 7 Necrosis is relatively frequent in testicular germ cell tumors and, if extensive, can preclude a routine histologic diagnosis. 9 The current study was performed to evaluate the utility of specific histologic features and a selected immunohistochemical panel in the diagnosis of necrotic testicular tumors.
MATERIALS AND METHODS
Predominantly necrotic testicular tumor resection specimens were retrieved from the consult files of 2 of the authors (T.M.U. and J.I.E.) between 2000 and 2008. Each of the cases was evaluated for the following histologic features: tumor size, intratubular germ cell neoplasia (IGCNU), seminiferous tubular atrophy/hyalinization, microlithiasis, coarse calcifications, associated granulation tissue, scarring, nodular Leydig cell hyperplasia (defined as nodular clusters of Leydig cells larger than the transverse diameter of 1 histologically normal seminiferous tubule), multifocal necrosis, inflammation, and tumor ''ghost'' cells. Inflammation was categorized as acute or chronic.
Each case that had available tissue was also evaluated immunohistochemically. Labeling was performed for keratin (AE1/AE3), OCT4, placental alkaline phosphatase (PLAP), a-fetoprotein (AFP), CD117, CD30, and S100. Four-micrometer sections were prepared from formalin-fixed, paraffin-embedded tissue samples. Immunohistochemical labeling was performed on the Ventana BenchMark XT automated stainer (Ventana) using the avidin-biotin method. All immunohistochemical assays were carried out after steammediated antigen retrieval. Appropriate positive and negative controls were performed. The source and dilution of each antibody are listed in Table 1 . A stain was scored as positive when there was distinct reactivity in a cellular distribution in the necrotic zone of the tumor; only nuclear reactivity was scored for OCT4 and membrane reactivity for CD117 and CD30.
An attempt was made to obtain clinical history and follow-up on each patient. Each patient was evaluated for the following parameters: chief complaint; additional relevant history; serum tumor markers; length of clinical follow-up; postresection treatment modality; presence of metastases; and mortality.
RESULTS
We identified 11 totally (n = 9) or almost totally (n = 2) necrotic testicular tumors. The latter 2 cases showed only a thin rim of viable tumor at the periphery of necrotic nodules, too scant in nature to permit routine diagnosis. The mean patient age was 35 years (range 16-63). The clinicopathologic findings for each case are listed in Table 2 . Although all 11 patients presented with unilateral testicular masses (6 right, 5 left), 2 men had additional acute pain. One patient had an elevated serum AFP level (>1000 ng/mL), and 1 had gynecomastia at presentation. A preliminary diagnosis was available for 9 of the cases. The contributing pathologist recognized a ''necrotic neoplasm'' in 5 cases (56%) (1 favored yolk sac tumor, 1 favored Leydig cell tumor, and 1 favored lymphoma); other preliminary diagnoses in 2 cases each were necrotizing granulomatous orchitis (22%) and testicular infarction (22%).
The histologic features are listed in Table 3 . The size of the lesions (measured microscopically) ranged from 7 to 53 mm, with an average of 19 mm. Each case showed 1 (10) or several (1) nodules of necrotic, eosinophilic material surrounded by a variably prominent fibrohistiocytic reaction (Figs. 1-3 ). Seminiferous tubular atrophy/ hyalinization (Fig. 4) , chronic inflammation, and tumor ''ghost'' cells (Figs. 1-3) were identified in 10 cases each. Scarring was seen in 9 cases. IGCNU, associated granulation tissue, and coarse intratubular calcifications ( Fig. 2) were identified in 6, 5, and 3 cases, respectively. All 3 cases with coarse intratubular calcifications were eventually diagnosed as embryonal carcinoma. Microlithiasis and multifocal necrosis were each identified in a single case. Neither acute inflammation nor nodular Leydig cell hyperplasia was identified in any of the cases. Nine of the cases were evaluated with immunohistochemistry (Table 4) . OCT4 was positive in 7 cases, CD117 and CD30 were positive in 3 cases each, and keratin and S100 were positive in 2 each. PLAP and AFP were negative in all cases examined.
The combination of histologic features, immunostains and, in 1 case, serum AFP permitted classification of 8 tumors (4 seminomas, 3 embryonal carcinomas, 1 yolk sac tumor). Three were not classifiable. The necrotic seminomas lacked associated coarse intratubular calcifications and were positive for OCT4 (4/4) and CD117 (3/3) but negative for keratin (0/4) and CD30 (0/4) (Fig. 1) . The necrotic embryonal carcinomas had associated coarse intratubular calcifications and were positive for keratin (2/3), OCT4 (2/2), and CD30 (3/3) but negative for CD117 (0/2) (Fig. 2) . One unclassifiable tumor stained for OCT4 but no additional specific markers (Fig. 3) , indicating it was either a seminoma or an embryonal carcinoma. In another unclassifiable tumor, only S100 stained positively.
Three cases were recent diagnoses, and 3 patients were lost to follow-up. Of the 5 patients with available follow-up information, 3 were tumor-free at 1, 5, and 8 years (2 necrotic seminomas and 1 germ cell tumor, unclassified). The remaining 2 patients were diagnosed with recurrent disease: the patient with necrotic yolk sac tumor developed widespread metastases and died from his tumor burden at 15 months despite aggressive chemotherapy; the other patient developed a large retroperitoneal seminoma at 16 months after being initially interpreted as ''testicular infarction (with) no malignancy.''
DISCUSSION
The diagnosis of a necrotic testicular mass can be challenging, particularly when the necrosis is widespread enough to mask the underlying histologic features of a lesion. This difficulty is highlighted by the fact that 44% of the necrotic germ cell tumors in our study were initially misinterpreted as either orchitis or benign testicular infarct by the original pathologist. When a necrotic testis is encountered, the initial diagnostic step should be to distinguish whether the necrosis is of testicular parenchyma or neoplastic tissue. A prime example of the former occurs with testicular torsion, which results in coagulative necrosis and hemorrhage in the parenchyma. The clinical presentation of infarction secondary to torsion and a necrotic tumor may be similar, as both may be associated with pain and testicular enlargement/mass. Two of our 11 patients with necrotic testicular tumors presented with acute pain. Residual outlines of evenly spaced seminiferous tubules throughout the testis provide confirmatory evidence of infarct. 3 Furthermore, the necrosis is diffuse in torsion, in contrast to what is seen in most neoplastic or inflammatory/infectious processes, which tend to involve a limited portion of the testis. Also although intermittent torsion rarely occurs, in most cases the testicle is obviously torsed at the time of surgery such that communication with the urologist regarding the intraoperative findings can be helpful.
General histologic features that favor neoplasm over a benign process (eg, testicular torsion, vasculitis, inflammation/infection) include atrophy/hyalinization of the seminiferous tubules surrounding the necrotic lesion, scarring, IGCNU, and tumor ''ghost'' cells. Atrophy/ hyalinization of seminiferous tubules was found in 10 cases and is not specific for a particular type of germ cell tumor but reflects the common background upon which many germ cell tumors develop. 4, 5 Scarring was seen in 9 of our cases, similar to the results found in earlier studies of primary testicular germ cell tumors with spontaneous regression.
1,2 Scarring may also be seen, however, in the presence of some benign processes, including ischemia and trauma, so its presence merely supports the diagnosis of a necrotic germ cell tumor, and is not specific for it. Chronic inflammation was identified in almost all cases of necrotic germ cell tumors but may also be seen in numerous benign inflammatory and infectious processes, making it less useful as a diagnostic feature of malignancy.
Although all of the above findings can be seen associated with germ cell tumors, they are not specific. There are 3 features, when present in a necrotic testicular lesion, which are either highly suggestive of, or specifically definitive for, the diagnosis of necrotic germ cell tumor. We identified coarse intratubular calcifications in 3 of our cases, all of which were diagnosed with embryonal carcinoma. Similar findings have been reported in the literature. 1, 8 This seems to be one of the most useful specific histologic features in necrotic germ cell tumors of the testis. Coarse intratubular calcifications that exceed the diameter of the seminiferous tubules represent the residual hallmark of regressed intratubular embryonal carcinoma, which commonly develops a comedo-type pattern of necrosis within expanded tubules that calcifies in a dystrophic fashion. IGCNU was identified in 6 cases, and confirms the necrotic lesion as a germ cell tumor but is not specific for a particular tumor, as confirmed by its occurrence in cases of 3 embryonal carcinomas, 2 unclassified germ cell tumors, and 1 seminoma in our study. This indicates that IGCNU is neither sensitive nor specific for any given histologic type of necrotic germ cell tumor. In addition to the importance of looking for IGCNU, careful attention to the histology of the necrotic tissue can in some cases reveal necrotic ghosts of tumor cells. Despite the necrosis, there may be sufficiently preserved cellular detail allowing not only the diagnosis of a necrotic germ cell tumor, but in some cases the recognition of the specific type of germ cell tumor. Three of our seminomas and 1 embryonal carcinoma had distinct cellular detail in the necrotic areas, making a specific histologic diagnosis possible even in the absence of viable tumor, although we recommend immunohistochemical confirmation.
Some histologic features did not have any bearing on the diagnosis of necrotic germ cell tumors, and were seen in few or none of our cases. We found that the presence or absence of microlithiasis, granulation tissue, nodular Leydig cell hyperplasia, and multifocal necrosis were not helpful. These data could be misleading, however, considering that most of our cases had widespread necrosis. Features such as nodular Leydig cell hyperplasia may be more readily identified with smaller lesions.
The fact that OCT4, CD117, keratin (AE1/AE3), and CD30 are useful stains in the diagnosis of germ cell tumors has been well-established. 8 However, the current study elucidates that these immunohistochemical stains can often be used even in completely necrotic testicular tissue, where the helpfulness of routine histology is greatly diminished. One of our cases (germ cell tumor, unclassified) did not stain positively for any marker except S100, which was a curious finding; metastatic melanoma was ruled-out in this case because other melanocytic markers (HMB-45, Melan-A, and MITF) were negative by immunohistochemistry and we subsequently have seen similar nonspecific S100 staining in another necrotic germ cell tumor that was not in the testis. AFP was negative immunohistochemically in all of the cases where it was available, and was unavailable in the 1 case diagnosed as yolk sac tumor based on markedly elevated serum AFP levels. This case serves as a reminder that serum tumor markers should be an integral part of the diagnostic protocol of any suspicious testicular lesion. 6 We did not find PLAP useful, which could be related to the fact that some markers are more sensitive to necrosis than others.
It is necessary to have a high index of suspicion that any necrotic lesion of the testis is a necrotic germ cell tumor until proven otherwise. Dealing with cases in this way will prevent the misdiagnosis of a malignant testicular lesion as a benign process. This is especially important as most of these tumors are seen in young patients, who would greatly benefit from the treatment options currently in place for germ cell tumor of the testis. The application of the morphologic criteria we have described in conjunction with a limited panel of immunohistochemical stains should permit the classification of most such cases into meaningful categories for appropriate clinical treatment. 
